Scholarly journal articles authored by members of the Division of Hematology/Oncology and the Henry Ford Cancer Institute at Henry Ford Health.

Follow


Submissions from 2022

PDF

Pembrolizumab in Combination with Chemotherapy in Patients with ERBB2-Mutated Non-Small Cell Lung Cancer, Fawzi Abu Rous, Radhika Gutta, Pin Li, Balazs Halmos, and Shirish M. Gadgeel

Link

Lung Cancer Treatment Advances in 2022, Fawzi Abu Rous, Eric K. Singhi, Arthi Sridhar, Muhammad Salman Faisal, and Aakash Desai

PDF

A Scoping Review of Strategies to Increase Black Enrollment and Retention in Cancer Clinical Trials, Noël M. Arring, Livingstone Aduse-Poku, Evelyn M. Jiagge, Kate Saylor, Denise White-Perkins, Barbara Israel, Eleanor M. Walker, Analise Hinebaugh, Rayya Harb, Jillian DeWitt, Maxim Molnar, Eliza Wilson-Powers, and Barbara L. Brush

PDF

Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain, Erik Berntorp, Petra LeBeau, Margaret V. Ragni, Munira Borhany, Yasmina L. Abajas, Michael D. Tarantino, Katharina Holstein, Stacy E. Croteau, Raina Liesner, Cristina Tarango, Manuela Carvalho, Catherine McGuinn, Eva Funding, Christine L. Kempton, Christoph Bidlingmaier, Alice Cohen, Johannes Oldenburg, Susan Kearney, Christine Knoll, Philip Kuriakose, Suchitra Acharya, Ulrike M. Reiss, Roshni Kulkarni, Michelle Witkop, Stefan Lethagen, Rebecca Krouse, Amy D. Shapiro, and Jan Astermark

PDF

A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC, D. Ross Camidge, Fabrice Barlesi, Jonathan W. Goldman, Daniel Morgensztern, Rebecca Heist, Everett Vokes, Eric Angevin, David S. Hong, Igor I. Rybkin, Minal Barve, Todd M. Bauer, Angelo Delmonte, Martin Dunbar, Monica Motwani, Apurvasena Parikh, Elysa Noon, Jun Wu, Vincent Blot, and Karen Kelly

Link

Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: a multicenter, open-label, phase 1b/2 trial, Macarena I. de la Fuente, Howard Colman, Mark Rosenthal, Brian A. Van Tine, Danijela Levacic, Tobias Walbert, Hui K. Gan, Maria Vieito, Mohammed M. Milhem, Kathryn Lipford, Sanjeev Forsyth, Sylvie M. Guichard, Yelena Mikhailov, Alexander Sedkov, Julie Brevard, Patrick F. Kelly, Hesham Mohamed, and Varun Monga

PDF

Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK+ Non-small Cell Lung Cancer in the Global Phase III ALEX Trial, Rafal Dziadziuszko, Solange Peters, Tony Mok, D. Ross Camidge, Shirish M. Gadgeel, Sai-Hong Ignatius Ou, Krzysztof Konopa, Johannes Noé, Malgorzata Nowicka, Walter Bordogna, Peter N. Morcos, Vlatka Smoljanovic, and Alice T. Shaw

PDF

Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium, Arielle Elkrief, Cassandra Hennessy, Nicole M. Kuderer, Samuel M. Rubinstein, Elizabeth Wulff-Burchfield, Rachel P. Rosovsky, Karen Vega-Luna, Michael A. Thompson, Orestis A. Panagiotou, Aakash Desai, Donna R. Rivera, Ali Raza Khaki, Lisa Tachiki, Ryan C. Lynch, Catherine Stratton, Rawad Elias, Gerald Batist, Anup Kasi, Dimpy P. Shah, Ziad Bakouny, Angelo Cabal, Jessica Clement, Jennifer Crowell, Becky Dixon, Christopher R. Friese, Stacy L. Fry, Punita Grover, Shuchi Gulati, Shilpa Gupta, Clara Hwang, Hina Khan, Soo Jung Kim, Elizabeth J. Klein, Chris Labaki, Rana R. McKay, Amanda Nizam, Nathan A. Pennell, Matthew Puc, Andrew L. Schmidt, Armin Shahrokni, Justin A. Shaya, Christopher T. Su, Sarah Wall, Nicole Williams, Trisha M. Wise-Draper, Sanjay Mishra, Petros Grivas, Benjamin French, Jeremy L. Warner, and Tanya M. Wildes

PDF

Demographic differences among patients treated with chimeric antigen receptor T-cell therapy in the United States, Josephine Emole, Odunayo Lawal, Oleksandra Lupak, Ajoy Dias, Leyla Shune, and Korede Yusuf

PDF

Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events: A Systematic Review and Meta-analysis., Muhammad Zain Farooq, Sheeba Ba Aqeel, Prasanth Lingamaneni, Rayli Pichardo, Aleeza Jawed, Saad Khalid, Shristi Upadhyay Banskota, Pingfu Fu, and Ankit Mangla

PDF

Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer, Genevieve A. Fasano, Solange Bayard, Yalei Chen, Leticia Varella, Tessa Cigler, Jessica Bensenhaver, Rache Simmons, Alexander Swistel, Jennifer Marti, Anne Moore, Eleni Andreopoulou, John Ng, Andrew Brandmaier, Silvia Formenti, Haythem Y. Ali, Melissa Davis, and Lisa Newman

PDF

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer, Julie Fu, Sonya A. Reid, Benjamin French, Cassandra Hennessy, Clara Hwang, Na Tosha Gatson, Narjust Duma, Sanjay Mishra, Ryan Nguyen, Jessica E. Hawley, Sunny R. K. Singh, David D. Chism, Neeta K. Venepalli, Jeremy L. Warner, Toni K. Choueiri, Andrew L. Schmidt, Leslie A. Fecher, Jennifer E. Girard, Mehmet A. Bilen, Deepak Ravindranathan, Sharad Goyal, Trisha M. Wise-Draper, Cathleen Park, Corrie A. Painter, Sheila M. McGlown, Gilberto de Lima Lopes, Oscar K. Serrano, and Dimpy P. Shah

PDF

Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non-Small Cell Lung Cancer: Results From the Randomized OAK Trial, Shirish M. Gadgeel, Fred R. Hirsch, Keith Kerr, Fabrice Barlesi, Keunchil Park, Achim Rittmeyer, Wei Zou, Namrata Bhatia, Hartmut Koeppen, Sarah M. Paul, David Shames, Jing Yi, Christina Matheny, Marcus Ballinger, Mark McCleland, and David R. Gandara

PDF

Response to "An approach to insulin tapering and discontinuation after glucagon-like peptide-1 receptor agonist initiation"., Jamie George, Nada Farhat, and Emily Thomas

PDF

Rapid Reductions in Breast Density following Tamoxifen Therapy as Evaluated by Whole-Breast Ultrasound Tomography, Gretchen L. Gierach, Mark Sak, Shaoqi Fan, Ruth M. Pfeiffer, Maya Palakal, Cody Ramin, Lisa Bey-Knight, Michael S. Simon, David Gorski, Haythem Y. Ali, Peter Littrup, Mark E. Sherman, and Nebojsa Duric

PDF

Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States, Jessica E. Hawley, Tianyi Sun, David D. Chism, Narjust Duma, Julie C. Fu, Na Tosha N. Gatson, Sanjay Mishra, Ryan H. Nguyen, Sonya A. Reid, Oscar K. Serrano, Sunny R. K. Singh, Neeta K. Venepalli, Ziad Bakouny, Babar Bashir, Mehmet A. Bilen, Paolo F. Caimi, Toni K. Choueiri, Scott J. Dawsey, Leslie A. Fecher, Daniel B. Flora, Christopher R. Friese, Michael J. Glover, Cyndi J. Gonzalez, Sharad Goyal, Thorvardur R. Halfdanarson, Dawn L. Hershman, Hina Khan, Chris Labaki, Mark A. Lewis, Rana R. McKay, Ian Messing, Nathan A. Pennell, Matthew Puc, Deepak Ravindranathan, Terence D. Rhodes, Andrea V. Rivera, John Roller, Gary K. Schwartz, Sumit A. Shah, Justin A. Shaya, Mitrianna Streckfuss, Michael A. Thompson, Elizabeth M. Wulff-Burchfield, Zhuoer Xie, Peter Paul Yu, Jeremy L. Warner, Dimpy P. Shah, Benjamin French, and Clara Hwang

PDF

Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysis, Tonaye Hinton, David Karnak, Ming Tang, Ralph Jiang, Yi Luo, Philip Boonstra, Yilun Sun, Derek J. Nancarrow, Erin Sandford, Paramita Ray, Christopher Maurino, Martha Matuszak, Matthew J. Schipper, Michael D. Green, Gregory A. Yanik, Muneesh Tewari, Issam El Naqa, Caitlin A. Schonewolf, Randall Ten Haken, Shruti Jolly, Theodore S. Lawrence, and Dipankar Ray

Link

Myeloid- and Epithelial-Derived HBEGF Promotes Pulmonary Fibrosis, Elissa M. Hult, Stephen J. Gurczynski, David N. O'Dwyer, Rachel L. Zemans, Andrew Rasky, Yizhuo Wang, Susan Murray, Howard C. Crawford, and Bethany B. Moore

Link

Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRAS(G12C) Mutation, Pasi A. Jänne, Gregory J. Riely, Shirish M. Gadgeel, Rebecca S. Heist, Sai-Hong I. Ou, Jose M. Pacheco, Melissa L. Johnson, Joshua K. Sabari, Konstantinos Leventakos, Edwin Yau, Lyudmila Bazhenova, Marcelo V. Negrao, Nathan A. Pennell, Jun Zhang, Kenna Anderes, Hirak Der-Torossian, Thian Kheoh, Karen Velastegui, Xiaohong Yan, James G. Christensen, Richard C. Chao, and Alexander I. Spira

PDF

Cardiac Rehabilitation Improves Fitness in Patients With Subclinical Markers of Cardiotoxicity While Receiving Chemotherapy: A RANDOMIZED CONTROLLED STUDY, Dennis J. Kerrigan, Madhulata Reddy, Eleanor M. Walker, Bernard Cook, James McCord, Randa Loutfi, Matthew A. Saval, Jodi Baxter, Clinton A. Brawner, and Steven J. Keteyian

PDF

Brief Report: Safety and Antitumor Activity of Alectinib Plus Atezolizumab From a Phase 1b Study in Advanced ALK-Positive NSCLC, Dong-Wan Kim, Shirish M. Gadgeel, Scott N. Gettinger, Gregory J. Riely, Geoffrey R. Oxnard, Tarek Mekhail, Peter Schmid, Afshin Dowlati, Rebecca S. Heist, Antoinette J. Wozniak, Jatinder Singh, Edward Cha, Jessica Spahn, and Sai-Hong Ignatius Ou

PDF

American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma: Systematic Review and Guidelines, Rachit Kumar, Leila Tchelebi, Christopher J. Anker, Navesh Sharma, Nancy A. Bianchi, Jadranka Dragovic, Karyn A. Goodman, Joseph M. Herman, Yixing Jiang, William E. Jones, Timothy J. Kennedy, Percy Lee, Madappa Kundranda, Suzanne Russo, William Small, Wonsuk W. Suh, Nelson Yee, and Salma K. Jabbour

PDF

Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy, Lucas G. Maahs, Ahmed I. Ghanem, Radhika Gutta, Amy Tang, Swarn Arya, Zaid Al-Saheli, Haythem Y. Ali, Steven S. Chang, Samantha Tam, Vivian Wu, Farzan Siddiqui, and Jawad Z. Sheqwara

PDF

Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations who progressed after platinum-based chemotherapy, Anna Minchom, Santiago Viteri, Lyudmila Bazhenova, Shirish M. Gadgeel, Sai-Hong Ignatius Ou, José Trigo, Joshua M. Bauml, Daniel Backenroth, Archan Bhattacharya, Tracy Li, Parthiv Mahadevia, and Nicolas Girard

PDF

A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis, Daniele Modonutti, Sami E. Majdalani, Nicholas Corsi, Pin Li, Akshay Sood, Deepansh Dalela, Marcus L. Jamil, Clara Hwang, Mani Menon, Craig G. Rogers, Quoc-Dien Trinh, Giacomo Novara, and Firas Abdollah

PDF

Concordance Between Tissue ALK Detection by Immunohistochemistry and Plasma ALK Detection by Next-Generation Sequencing in the Randomized Phase 3 ALEX Study in Patients With Treatment-Naive Advanced ALK-Positive NSCLC, Johannes Noé, Walter Bordogna, Venice Archer, Vlatka Smoljanovic, Magalie Hilton, Ryan Woodhouse, Simonetta Mocci, and Shirish M. Gadgeel

Link

First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRAS(G12C) Solid Tumors (KRYSTAL-1), Sai-Hong Ignatius Ou, Pasi A. Jänne, Ticiana A. Leal, Igor I. Rybkin, Joshua K. Sabari, Minal A. Barve, Lyudmila A. Bazhenova, Melissa L. Johnson, Karen L. Velastegui, Cornelius Cilliers, James G. Christensen, Xiaohong Yan, Richard C. Chao, and Kyriakos P. Papadopoulos

PDF

Continuation of Lorlatinib in ALK-Positive NSCLC Beyond Progressive Disease, Sai-Hong I. Ou, Benjamin J. Solomon, Alice T. Shaw, Shirish M. Gadgeel, Benjamin Besse, Ross A. Soo, Antonello Abbattista, Francesca Toffalorio, Robin Wiltshire, and Alessandra Bearz

PDF

Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors, Amita Patnaik, Shirish M. Gadgeel, Kyriakos P. Papadopoulos, Drew W. Rasco, Naomi B. Haas, Hirak Der-Torossian, Demiana Faltaos, Diane Potvin, Vanessa Tassell, Manal Tawashi, Richard Chao, and Peter J. O'Dwyer

PDF

Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial, Solange Peters, Rafal Dziadziuszko, Alessandro Morabito, Enriqueta Felip, Shirish M. Gadgeel, Parneet Cheema, Manuel Cobo, Zoran Andric, Carlos H. Barrios, Masafumi Yamaguchi, Eric Dansin, Pongwut Danchaivijitr, Melissa Johnson, Silvia Novello, Michael S. Mathisen, Sarah M. Shagan, Erica Schleifman, Jin Wang, Mark Yan, Simonetta Mocci, David Voong, David A. Fabrizio, David S. Shames, Todd Riehl, David R. Gandara, and Tony Mok

Link

Comparison Between the 2021 USPSTF Lung Cancer Screening Criteria and Other Lung Cancer Screening Criteria for Racial Disparity in Eligibility, Chan Yeu Pu, Christine M. Lusk, Christine Neslund-Dudas, Shirish M. Gadgeel, Ayman O. Soubani, and Ann G. Schwartz

PDF

Lung Cancer Screening Criteria and Cardiopulmonary Comorbidities, Chan Yeu Pu, Christine M. Lusk, Christine Neslund-Dudas, Shirish M. Gadgeel, Ayman O. Soubani, and Ann G. Schwartz

PDF

Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a CCC19 registry analysis, Samuel M. Rubinstein, Divaya Bhutani, Ryan C. Lynch, Chih-Yuan Hsu, Yu Shyr, Shailesh Advani, Ruben A. Mesa, Sanjay Mishra, Daniel P. Mundt, Dimpy P. Shah, R. Alejandro Sica, Keith E. Stockerl-Goldstein, Catherine Stratton, Matthias Weiss, Alicia Beeghly-Fadiel, Melissa Accordino, Sarit E. Assouline, Joy Awosika, Ziad Bakouny, Babar Bashir, Stephanie Berg, Mehmet Asim Bilen, Cecilia A. Castellano, Jacob C. Cogan, Devendra Kc, Christopher R. Friese, Shilpa Gupta, Daniel Hausrath, Clara Hwang, Nathalie A. Johnson, Monika Joshi, Anup Kasi, Elizabeth J. Klein, Vadim S. Koshkin, Nicole M. Kuderer, Daniel H. Kwon, Chris Labaki, Tahir Latif, Eric Lau, Xuanyi Li, Gary H. Lyman, Rana R. McKay, Gayathri Nagaraj, Amanda Nizam, Taylor K. Nonato, Adam J. Olszewski, Hyma V. Polimera, Andrew J. Portuguese, Matthew M. Puc, Pedram Razavi, Rachel Rosovski, Andrew Schmidt, Sumit A. Shah, Aditi Shastri, Christopher Su, Pallawi Torka, Trisha M. Wise-Draper, Leyre Zubiri, Jeremy L. Warner, and Michael A. Thompson

PDF

Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study, Gowri Satyanarayana, Kyle T. Enriquez, Tianyi Sun, Elizabeth J. Klein, Maheen Abidi, Shailesh M. Advani, Joy Awosika, Ziad Bakouny, Babar Bashir, Stephanie Berg, Marilia Bernardes, Pamela C. Egan, Arielle Elkrief, Lawrence E. Feldman, Christopher R. Friese, Shipra Goel, Cyndi Gonzalez Gomez, Keith L. Grant, Elizabeth A. Griffiths, Shuchi Gulati, Shilpa Gupta, Clara Hwang, Jayanshu Jain, Chinmay Jani, Anna Kaltsas, Anup Kasi, Hina Khan, Natalie Knox, Vadim S. Koshkin, Daniel H. Kwon, Chris Labaki, Gary H. Lyman, Rana R. McKay, Christopher McNair, Gayathri Nagaraj, Elizabeth S. Nakasone, Ryan Nguyen, Taylor K. Nonato, Adam J. Olszewski, Orestis A. Panagiotou, Matthew Puc, Pedram Razavi, Elizabeth V. Robilotti, Miriam Santos-Dutra, Andrew L. Schmidt, Dimpy P. Shah, Sumit A. Shah, Kendra Vieira, Lisa B. Weissmann, Trisha M. Wise-Draper, Ulysses Wu, Julie Tsu-Yu Wu, Toni K. Choueiri, Sanjay Mishra, Jeremy L. Warner, Benjamin French, and Dimitrios Farmakiotis

Link

COVID-19 vaccination and breakthrough infections in patients with cancer, A L Schmidt, C Labaki, C-Y Hsu, Z Bakouny, Nino Balanchivadze, S A Berg, S Blau, A Daher, T El Zarif, C R Friese, E A Griffiths, J E Hawley, B Hayes-Lattin, V Karivedu, T Latif, B H Mavromatis, R R McKay, G Nagaraj, R H Nguyen, O A Panagiotou, A J Portuguese, M Puc, M Santos Dutra, B A Schroeder, A Thakkar, E M Wulff-Burchfield, S Mishra, D Farmakiotis, Yu Shyr, J L Warner, and T K Choueiri

PDF

Personal Systemic Therapy Decision-Making has Officially Arrived for Node-Positive Breast Cancer, Theresa Schwartz

PDF

The Need for Rapid Cytogenetics in the Era of Unique Therapies for Acute Myeloid Leukemia, Anjanaa Vijayanarayanan, Brandon M. Shaw, Kathryn Gibbons, Kedar V. Inamdar, Philip Kuriakose, and Madhu P. Menon

PDF

Clinical outcomes of preimplantation genetic testing for hereditary cancer syndromes: A systematic review, Natalie Vriesen, Erin P. Carmany, and Jaime L. Natoli

Submissions from 2021

PDF

Outcomes of patients with thrombocytopenia evaluated at hematology subspecialty clinics, Zaid H. Abdel Rahman, Kevin C. Miller, H Jabbour, Yaser Alkhatib, and Vijayalakshmi Donthireddy

PDF

Renal infarction and papular-purpuric gloves and socks syndrome (PPGSS): rare extra-haematological manifestations of acute parvovirus B-19 infection, Fawzi Abu Rous, Qunfang Li, and Yue Guo

PDF

Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents, Mohamed Alhamar, Bassam Alkamachi, Harshita Mehrotra, Jessica Sanchez, Haythem Y. Ali, Daniel Schultz, and Dhananjay A. Chitale

PDF

p16 positive oropharyngeal small cell cancer: A case report, Nada Al Masalmeh, Geetika Kukreja, Feras Zaiem, S. Naweed Raza, Harold Kim, Misako Nagasaka, and Ammar Sukari

PDF

A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811), Athanassios Argiris, Jieling Miao, Mihaela C. Cristea, Allen M. Chen, Jacob M. Sands, Roy H. Decker, Scott N. Gettinger, Megan E. Daly, Bryan A. Faller, Kathy S. Albain, Ronald H. Yanagihara, Linda L. Garland, Lauren A. Byers, Ding Wang, Marianna Koczywas, Mary W. Redman, Karen Kelly, and David R. Gandara

PDF

P-selectin expression assay in a repeatedly serotonin-release assay-negative patient with heparin-induced thrombocytopenia, Kanika Arora, Shannon Rodgers, Yaser Alkhatib, Ifeoma Onwubiko, Anand Padmanabhan, and Zaher K. Otrock

PDF

Acquired Resistance to KRAS (G12C) Inhibition in Cancer, Mark M. Awad, Shengwu Liu, Igor I. Rybkin, Kathryn C. Arbour, Julien Dilly, Viola W. Zhu, Melissa L. Johnson, Rebecca S. Heist, Tejas Patil, Gregory J. Riely, Joseph O. Jacobson, Xiaoping Yang, Nicole S. Persky, David E. Root, Kristen E. Lowder, Hanrong Feng, Shannon S. Zhang, Kevin M. Haigis, Yin P. Hung, Lynette M. Sholl, Brian M. Wolpin, Julie Wiese, Jason Christiansen, Jessica Lee, Alexa B. Schrock, Lee P. Lim, Kavita Garg, Mark Li, Lars D. Engstrom, Laura Waters, J. David Lawson, Peter Olson, Piro Lito, Sai-Hong I. Ou, James G. Christensen, Pasi A. Jänne, and Andrew J. Aguirre

PDF

A Case of Chronic Eosinophilic Leukemia in a Patient With Recurrent Cough, Dyspnea, and Eosinophilia, Nino Balanchivadze, James P. Purtell, Jessica Anderson, Yue Guo, and Irina Dobrosotskaya

PDF

NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer, Julie E. Bauman, Jonathan Harris, Ravindra Uppaluri, Min Yao, Robert L. Ferris, Josephine Chen, Richard C. Jordan, Nikhil P. Joshi, Srinivas Jujjuvaparu, Dukagjin M. Blakaj, Christina Henson, Jawad Sheqwara, Loren K. Mell, Neilayan Sen, David A. Clump, Madhur K. Garg, Emrullah Yilmaz, Pedro Torres-Saavedra, and Quynh-Thu Le

PDF

Screening mammography mitigates breast cancer disparities through early detection of triple negative breast cancer, Solange Bayard, Genevieve Fasano, Yalei Chen, Melissa Davis, Michele Drotman, Jessica Bensenhaver, Alexander Swistel, Rache Simmons, Jennifer Marti, and Lisa Newman

PDF

Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations, Lyudmila Bazhenova, Anna Minchom, Santiago Viteri, Joshua M. Bauml, Sai-Hong Ignatius Ou, Shirish M. Gadgeel, José Manuel Trigo, Daniel Backenroth, Tracy Li, Anil Londhe, Parthiv Mahadevia, and Nicolas Girard

PDF

Discovery of the pancreatic basal cell: a new candidate for an adult stem cell emerges, Simone Benitz and Howard C. Crawford

PDF

Anticipating resistance to KRAS inhibition: a novel role for USP21 in macropinocytosis regulation, Howard C. Crawford

PDF

Loss of the ciliary protein Chibby1 in mice leads to exocrine pancreatic degeneration and pancreatitis, Benjamin Cyge, Vera Voronina, Mohammed Hoque, Eunice N. Kim, Jason Hall, Jennifer M. Bailey-Lundberg, Gregory J. Pazour, Howard C. Crawford, Randall T. Moon, Feng-Qian Li, and Ken-Ichi Takemaru

Link

Portobelamides A and B and Caciqueamide, Cytotoxic Peptidic Natural Products from a Caldora sp. Marine Cyanobacterium, Ozlem Demirkiran, Jehad Almaliti, Tiago Leão, Gabriel Navarro, Tara Byrum, Frederick A. Valeriote, Lena Gerwick, and William H. Gerwick

PDF

Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer, Tru-Khang T. Dinh, Timur Mitin, Hilary P. Bagshaw, Karen E. Hoffman, Clara Hwang, R. Jeffrey Karnes, Amar U. Kishan, Stanley L. Liauw, Shane Lloyd, Louis Potters, Timothy N. Showalter, Al V. Taira, Neha Vapiwala, Nicholas G. Zaorsky, Anthony V. D'Amico, Paul L. Nguyen, and Brian J. Davis

PDF

Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC: Initial Results of the Phase 2 ALK-Positive Cohort, Rafal Dziadziuszko, Tony Mok, Solange Peters, Ji-Youn Han, Jorge Alatorre-Alexander, Natasha Leighl, Virote Sriuranpong, Maurice Pérol, Gilberto de Castro Junior, Ernest Nadal, Filippo de Marinis, Osvaldo Arén Frontera, Daniel S W Tan, Dae Ho Lee, Hye Ryun Kim, Mark Yan, Todd Riehl, Erica Schleifman, Sarah M. Paul, Simonetta Mocci, Rajesh Patel, Zoe June Assaf, David S. Shames, Michael S. Mathisen, and Shirish M. Gadgeel

Link

Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma, Jessica L. Fleming, Stephanie L. Pugh, Barbara J. Fisher, Glenn J. Lesser, David R. Macdonald, Erica H. Bell, Joseph P. McElroy, Aline P. Becker, Cynthia D. Timmers, Kenneth D. Aldape, C. Leland Rogers, Thomas J. Doyle, Maria Werner-Wasik, Jean-Paul Bahary, Hsiang-Hsuan Michael Yu, David P. D'Souza, Nadia N. Laack, Penny K. Sneed, Young Kwok, Minhee Won, Minesh P. Mehta, and Arnab Chakravarti

Link

Patient-Reported Outcomes in the Era of Immunotherapy Trials, Shirish M. Gadgeel

PDF

Fast progression in non-small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxel, David Gandara, Martin Reck, Denis Moro-Sibilot, Julien Mazieres, Shirish M. Gadgeel, Stefanie Morris, Andres Cardona, Diana Mendus, Marcus Ballinger, Achim Rittmeyer, and Solange Peters

PDF

Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189, Edward B. Garon, Joachim Aerts, Jong Seok Kim, Catherine E Muehlenbein, Patrick Peterson, Maria Teresa Rizzo, and Shirish M. Gadgeel

PDF

The actual and ideal roles of haemophilia treatment centre social workers in the United States and the barriers to ideal roles, Margaret K. Geary, Ellen Kachalsky, and Aric Parnes

Link

Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study, Gareth Peter Gregory, Shaji K. Kumar, Ding Wang, Daruka Mahadevan, Patricia A. Walker, Nina D. Wagner-Johnston, Carolina Escobar, Rajat Bannerji, Divava Bhutani, Julie E. Chang, Francisco J. Hernandez-Ilizaliturri, Andreas Klein, John M. Pagel, Witold Rybka, Andrew J. Yee, Anne Mohrbacher, Mo Huang, Mohammed Z. H. Farooqui, Patricia Marinello, and Hang Quach

PDF

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium, P Grivas, A R Khaki, T M Wise-Draper, B French, C Hennessy, C-Y Hsu, Y Shyr, X Li, T K Choueiri, C A Painter, S Peters, B I Rini, M A Thompson, S Mishra, D R Rivera, J D Acoba, M Z Abidi, Z Bakouny, B Bashir, T Bekaii-Saab, S Berg, E H Bernicker, M A Bilen, P Bindal, R Bishnoi, N Bouganim, D W Bowles, A Cabal, P F Caimi, D D Chism, J Crowell, C Curran, A Desai, B Dixon, D B Doroshow, E B Durbin, A Elkrief, D Farmakiotis, A Fazio, L A Fecher, D B Flora, C R Friese, J Fu, Shirish M. Gadgeel, M D Galsky, D M Gill, M J Glover, S Goyal, P Grover, S Gulati, S Gupta, S Halabi, T R Halfdanarson, B Halmos, D J Hausrath, J E Hawley, E Hsu, M Huynh-Le, Clara Hwang, C Jani, A Jayaraj, D B Johnson, A Kasi, H Khan, V S Koshkin, N M Kuderer, D H Kwon, P E Lammers, A Li, A Loaiza-Bonilla, C A Low, M B Lustberg, G H Lyman, R R McKay, C McNair, H Menon, R A Mesa, V Mico, D Mundt, G Nagaraj, E S Nakasone, J Nakayama, A Nizam, N L Nock, C Park, J M Patel, K G Patel, P Peddi, N A Pennell, A J Piper-Vallillo, M Puc, D Ravindranathan, M E Reeves, D Y Reuben, L Rosenstein, R P Rosovsky, S M Rubinstein, M Salazar, A L Schmidt, G K Schwartz, M R Shah, S A Shah, C Shah, J A Shaya, Sunny R.K. Singh, M Smits, K E Stockerl-Goldstein, D G Stover, M Streckfuss, S Subbiah, L Tachiki, E Tadesse, A Thakkar, M D Tucker, A K Verma, D C Vinh, M Weiss, J T Wu, E Wulff-Burchfield, Z Xie, P P Yu, T Zhang, A Y Zhou, H Zhu, L Zubiri, D P Shah, J L Warner, and GdL Lopes

PDF

Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature, Wouter S. Hoogenboom, Tharun T. Alamuri, Daniel M. McMahon, Nino Balanchivadze, Vrushali Dabak, William B. Mitchell, Kerry B. Morrone, Deepa Manwani, and Tim Q. Duong

PDF

Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK + advanced tumors, Felipe K. Hurtado, Filippo de Braud, Javier De Castro Carpeño, Maria Jose de Miguel Luken, Ding Wang, Jeffrey Scott, Yvonne Y. Lau, Tracey McCulloch, and Morten Mau-Sorensen

PDF

Rapid real-world data analysis of patients with cancer, with and without COVID-19, across distinct health systems, Clara Hwang, Monika A. Izano, Michael A. Thompson, Shirish M. Gadgeel, James L. Weese, Tom Mikkelsen, Andrew Schrag, Mahder Teka, Sheetal Walters, Frank M. Wolf, Jonathan Hirsch, Donna R. Rivera, Paul G. Kluetz, Harpreet Singh, and Thomas D. Brown

PDF

Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry, Evelyn M. Jiagge, Peter J. Ulintz, Shukmei Wong, Sean P. McDermott, Sabrina I. Fossi, Tahra K. Suhan, Mark J. Hoenerhoff, Jessica M. Bensenhaver, Barbara Salem, Michele Dziubinski, Joseph K. Oppong, Francis Aitpillah, Kyei Ishmael, Ernest Osei-Bonsu, Ernest Adjei, Awuah Baffour, Jessica Aldrich, Ahmet Kurdoglu, Kurt Fernando, David W. Craig, Jeff M. Trent, Jun Li, Dhananjay A. Chitale, Lisa A. Newman, John D. Carpten, Max S. Wicha, and Sofia D. Merajver

PDF

The long shadow of socioeconomic deprivation over the modern management of acute myeloid leukemia: time to unravel the challenges, M. Joseph John, Philip Kuriakose, Mark Smith, Eve Roman, and Sudhir Tauro

PDF

Apolipoprotein E promotes immune suppression in pancreatic cancer through NF-kB-mediated production of CXCL1, Samantha B. Kemp, Eileen S. Carpenter, Nina G. Steele, Katelyn L. Donahue, Zeribe Chike Nwosu, Amanda Pacheco, Ashley Velez-Delgado, Rosa E. Menjivar, Fatima Lima, Stephanie The, Carlos E. Espinoza, Kristee Brown, Daniel Long, Costas A. Lyssiotis, Arvind Rao, Yaqing Zhang, Marina Pasca di Magliano, and Howard C. Crawford

PDF

Myeloid Cell Mediated Immune Suppression in Pancreatic Cancer, Samantha B. Kemp, Marina Pasca di Magliano, and Howard C. Crawford

PDF

PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer, Vadim S. Koshkin, Vaibhav G. Patel, Alicia Ali, Mehmet A. Bilen, Deepak Ravindranathan, Joseph J. Park, Olesia Kellezi, Marcin Cieslik, Justin Shaya, Angelo Cabal, Landon Brown, Matthew Labriola, Laura S. Graham, Colin Pritchard, Abhishek Tripathi, Sanober Nusrat, Pedro Barata, Albert Jang, Shuang R. Chen, Rohan Garje, Luna Acharya, Clara Hwang, Amanda B. Pilling, William Oh, Tomi Jun, Divya Natesan, Chris Nguyen, Deepak Kilari, Michael Pierro, Bicky Thapa, Frank Cackowski, Alleda Mack, Elisabeth Heath, Catherine H. Marshall, Scott T. Tagawa, Susan Halabi, Michael T. Schweizer, Andrew Armstrong, Tanya Dorff, Ajjai Alva, and Rana McKay

PDF

Association between ibrutinib treatment and hypertension, Dae Hyun Lee, Fahad Hawk, Kieun Seok, Matthew Gliksman, Josephine Emole, Isaac B. Rhea, Federico Viganego, Allan Welter-Frost, Merna Armanious, Bijal Shah, Juliio C. Chavez, Javier Pinilla-Ibarz, Matthew B. Schabath, and Michael Fradley

PDF

The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19, Ang Li, Nicole M. Kuderer, Chih-Yuan Hsu, Yu Shyr, Jeremy L. Warner, Dimpy P. Shah, Vaibhav Kumar, Surbhi Shah, Amit A. Kulkarni, Julie Fu, Shuchi Gulati, Rebecca L. Zon, Monica Li, Aakash Desai, Pamela C. Egan, Ziad Bakouny, Devendra Kc, Clara Hwang, Imo J. Akpan, Rana R. McKay, Jennifer Girard, Andrew L. Schmidt, Balazs Halmos, Michael A. Thompson, Jaymin M. Patel, Nathan A. Pennell, Solange Peters, Amro Elshoury, Gilbero de Lima Lopes, Daniel G. Stover, Petros Grivas, Brian I. Rini, Corrie A. Painter, Sanjay Mishra, Jean M. Connors, Gary H. Lyman, and Rachel P. Rosovsky

PDF

Disparities in Utilization of Autologous Stem Cell Transplantation as Consolidative Therapy for Multiple Myeloma: A Single Institution Retrospective Review, Oleksandra Lupak, Xiaoxia Han, Peter Xie, Kannan Thanikachalam, Hiba Jabbour-Aida, Shatha Farhan, and Josephine Emole

PDF

Outcomes of in-hospital cardiopulmonary resuscitation for cardiac arrest in adult patients with metastatic solid cancers: A Nationwide Inpatient Sample database analysis from 2012 to 2014, Sindhu Malapati, Sunny R.K. Singh, Rohit Kumar, and Tarik Hadid

PDF

What Matters Most? Predictors of Quality of Life and Life Satisfaction Among Young Breast Cancer Survivors, Kellie Martens, Gillian R. Ulrich, Krista W. Ranby, and Kristin Kilbourn

PDF

Evolution of the Cancer Registrar in the Era of Informatics, Kelly W. Merriman, Ronda G. Broome, Giordana De Las Pozas, Lisa D. Landvogt, Ying Qi, and Judith Keating

PDF

Tribbles 2 pseudokinase confers enzalutamide resistance in prostate cancer by promoting lineage plasticity, Jitender Monga, Indra Adrianto, Craig G. Rogers, Shirish M. Gadgeel, Dhananjay A. Chitale, Joshi J. Alumkal, Himisha Beltran, Amina Zoubeidi, and Jagadananda Ghosh

PDF

Adenoid cystic carcinoma of the labium oris with rare metastasis to the pleural cavity, Osama Mosalem, Anas Alsara, Fawzi Abu Rous, and Borys Hrinczenko

Link

Impact of Oral Chemotherapy Management Program on Capecitabine Toxicity Management, Salin Nhean, Diana Kostoff, Jessica J. Yang, Vishnuprabha Vogel, and Igor I. Rybkin

Link

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes, Betül Oran, Kwang Woo Ahn, Caitrin Fretham, Amer Beitinjaneh, Asad Bashey, Attaphol Pawarode, Baldeep Wirk, Bart L. Scott, Bipin N. Savani, Christopher Bredeson, Daniel Weisdorf, David I. Marks, David Rizzieri, Edward Copelan, Gerhard C. Hildebrandt, Gregory A. Hale, Hemant S. Murthy, Hillard M. Lazarus, Jan Cerny, Jane L. Liesveld, Jean A. Yared, Jean Yves-Cahn, Jeffrey Szer, Leo F. Verdonck, Mahmoud Aljurf, Marjolein van der Poel, Mark Litzow, Matt Kalaycio, Michael R. Grunwald, Miguel Angel Diaz, Mitchell Sabloff, Mohamed A. Kharfan-Dabaja, Navneet S. Majhail, Nosha Farhadfar, Ran Reshef, Richard F. Olsson, Robert Peter Gale, Ryotaro Nakamura, Sachiko Seo, Saurabh Chhabra, Shahrukh Hashmi, Shatha Farhan, Siddhartha Ganguly, Sunita Nathan, Taiga Nishihori, Tania Jain, Vaibhav Agrawal, Ulrike Bacher, Uday Popat, and Wael Saber

PDF

Thrombocytapheresis for acquired von Willebrand syndrome in a patient with essential thrombocythemia and recent multivisceral transplantation, Oluwayomi Oyedeji, Jawad Sheqwara, Ifeoma Onwubiko, Ileana Lopez-Plaza, Shunji Nagai, and Zaher K. Otrock

PDF

Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancer, Amanda B. Pilling, Sahn-Ho Kim, and Clara Hwang

Link

Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors, Angel Qin, Songzhu Zhao, Abdul Miah, Lai Wei, Sandipkumar Patel, Andrew Johns, Madison Grogan, Erin M. Bertino, Kai He, Peter G. Shields, Gregory P. Kalemkerian, Shirish M. Gadgeel, Nithya Ramnath, Bryan J. Schneider, Khaled A. Hassan, Nicholas Szerlip, Zoey Chopra, Sara Journey, Jessica Waninger, Daniel Spakowicz, David P. Carbone, Carolyn J. Presley, Gregory A. Otterson, Michael D. Green, and Dwight H. Owen

PDF

Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations From a Phase 1/2 Trial, Gregory J. Riely, Joel W. Neal, D. Ross Camidge, Alexander I. Spira, Zofia Piotrowska, Daniel B. Costa, Anne S. Tsao, Jyoti D. Patel, Shirish M. Gadgeel, Lyudmila Bazhenova, Viola W. Zhu, Howard L. West, Tarek Mekhail, Ryan D. Gentzler, Danny Nguyen, Sylvie Vincent, Steven Zhang, Jianchang Lin, Veronica Bunn, Shu Jin, Shuanglian Li, and Pasi A. Janne

PDF

Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19, Andrew L. Schmidt, Matthew D. Tucker, Ziad Bakouny, Chris Labaki, Chih-Yuan Hsu, Yu Shyr, Andrew J. Armstrong, Tomasz M. Beer, Ragneel R. Bijjula, Mehmet A. Bilen, Cindy F. Connell, Scott Joseph Dawsey, Bryan Faller, Xin Gao, Benjamin A. Gartrell, David Gill, Shuchi Gulati, Susan Halabi, Clara Hwang, Monika Joshi, Ali Raza Khaki, Harry Menon, Michael J. Morris, Matthew Puc, Karen B. Russell, Neil J. Shah, Nima Sharifi, Justin Shaya, Michael T. Schweizer, John Steinharter, Elizabeth M. Wulff-Burchfield, Wenxin Xu, Jay Zhu, Sanjay Mishra, Petros Grivas, Brian I. Rini, Jeremy Lyle Warner, Tian Zhang, Toni K. Choueiri, Shilpa Gupta, and Rana R. McKay

PDF

Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural), Amy D. Shapiro, Margaret V. Ragni, Munira Borhany, Yasmina L. Abajas, Michael D. Tarantino, Katharina Holstein, Stacy E. Croteau, Riana Liesner, Cristina Tarango, Manuela Carvalho, Catherine McGuinn, Eva Funding, Christine L. Kempton, Christoph Bidlingmaier, Alice Cohen, Johannes Oldenburg, Susan Kearney, Christine Knoll, Philip Kuriakose, Suchitra Acharya, Ulrike M. Reiss, Roshni Kulkarni, Michelle Witkop, Stefan Lethagen, Sharyne Donfield, Petra LeBeau, Erik Berntorp, and Jan Astermark

PDF

NCDB analysis of melanoma 2004–2015: Epidemiology and outcomes by subtype, sociodemographic factors impacting clinical presentation, and real‐world survival benefit of immunotherapy approval, Sunny R.K. Singh, Sindhu J. Malapati, Rohit Kumar, Christopher Willner, and Ding Wang

PDF

First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors, Lillian L. Siu, Ding Wang, John Hilton, Ravit Geva, Drew Rasco, Ruth Perets, Anson K. Abraham, Douglas C. Wilson, Julia F. Markensohn, Jared Lunceford, Leah Suttner, Shabana Siddiqi, Rachel A. Altura, and Corinne Maurice-Dror

PDF

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort, Benjamin Tan, Adnan Khattak, Enriqueta Felip, Karen Kelly, Patricia Rich, Ding Wang, Christoph Helwig, Isabelle Dussault, Laureen S. Ojalvo, and Nicolas Isambert

PDF

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19, Michael A. Thompson, Jeffrey P. Henderson, Pankil K. Shah, Samuel M. Rubinstein, Michael J. Joyner, Toni K. Choueiri, Daniel B. Flora, Elizabeth A. Griffiths, Anthony P. Gulati, Clara Hwang, Vadim S. Koshkin, Esperanza B. Papadopoulos, Elizabeth V. Robilotti, Christopher T. Su, Elizabeth M. Wulff-Burchfield, Zhuoer Xie, Peter Paul Yu, Sanjay Mishra, Jonathon W. Senefeld, Dimpy P. Shah, and Jeremy L. Warner

PDF

Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Clinical Trial, Ulka N. Vaishampayan, Lance K. Heilbrun, Paul Monk, Sheela Tejwani, Guru Sonpavde, Clara Hwang, Daryn Smith, Pallavi Jasti, Kimberlee Dobson, Brenda Dickow, Elisabeth I. Heath, Louie Semaan, Michael L. Cher, Joseph A. Fontana, and Sreenivasa Chinni

PDF

KDM6A Regulates Cell Plasticity and Pancreatic Cancer Progression by Non-Canonical Activin Pathway, Zhujun Yi, Shanqiao Wei, Lin Jin, Sivakumar Jeyarajan, Jing Yang, Yumei Gu, Hong Sun Kim, Shula Schechter, Shuang Lu, Michelle T. Paulsen, Karan Bedi, Ishwarya Venkata Narayanan, Mats Ljungman, Howard C. Crawford, Marina Pasca di Magliano, Kai Ge, Yali Dou, and Jiaqi Shi

PDF

Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan, Kenneth H. Yu, Andrew E. Hendifar, Olatunji B. Alese, Amber Draper, Maen Abdelrahim, Ethan Burns, Gazala Khan, Paul Cockrum, Rachel H. Bhak, Catherine Nguyen, Maral DerSarkissian, Mei Sheng Duh, and Nathan Bahary

Submissions from 2020

PDF

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis, Andrea B. Apolo, John A. Ellerton, Jeffrey R. Infante, Manish Agrawal, Michael S. Gordon, Raid Aljumaily, Theodore Gourdin, Luc Dirix, Keun-Wook Lee, Matthew H. Taylor, Patrick Schöffski, Ding Wang, Alain Ravaud, Juliane Manitz, Gregory Pennock, Mary Ruisi, James L. Gulley, and Manish R. Patel

Link

Heterogeneity at the invasion front of triple negative breast cancer cells, Koh Meng Aw Yong, Peter J. Ulintz, Sara Caceres, Xu Cheng, Liwei Bao, Zhifen Wu, Evelyn M. Jiagge, and Sofia D. Merajver

Link

Hematology/Oncology Fellowship Emergency Restructuring in Response to the COVID-19 Pandemic—Henry Ford Hospital, Michigan, Nino Balanchivadze and Vijayalakshmi Donthireddy

Link

Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease One Center Urban Experience, Detroit, MI, USA, Nino Balanchivadze, Adam A. Kudirka, Sally FK Askar, Khaled Almadhoun, Philip Kuriakose, Raef Fadel, and Vrushali Dabak

PDF

American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020, Stephen G. Chun, Charles B. Simone, Arya Amini, Indrin J. Chetty, Jessica Donington, Martin J. Edelman, Kristin A. Higgins, Larry L. Kestin, Benjamin Movsas, George B. Rodrigues, Kenneth E. Rosenzweig, Ben J. Slotman, Igor I. Rybkin, Andrea Wolf, and Joe Y. Chang

Link

Synthesis, Cytotoxicity, and Genotoxicity of 10-Aza-9-oxakalkitoxin, an N,N,O-Trisubstituted Hydroxylamine Analog, or Hydroxalog, of a Marine Natural Product, Sandeep Dhanju, Kapil Upadhyaya, Christopher A. Rice, Scott D. Pegan, Joe Media, Frederick A. Valeriote, and David Crich

Link

Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study, Susan M. Domchek, Sophie Postel-Vinay, Seock-Ah Im, Yeon Hee Park, Jean-Pierre Delord, Antoine Italiano, Jerome Alexandre, Benoit You, Sara Bastian, Matthew G Krebs, Ding Wang, Saiama N. Waqar, Mark Lanasa, Joon Rhee, Haiyan Gao, Vidalba Rocher-Ros, Emma V. Jones, Sakshi Gulati, Anna Coenen-Stass, Iwanka Kozarewa, Zhongwu Lai, Helen K. Angell, Laura Opincar, Pia Herbolsheimer, and Bella Kaufman